Form EFFECT Clearmind Medicine Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 18, 2026 |
| Accession Number: | 0001213900-26-068893 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearmind completes Part A of FDA-regulated AUD drug trial
- American Fusion(TM) Inc. (AMFN) Expands Patent Portfolio Targeting Future Commercial Texatron(TM) Fusion Engine(TM) Platform
- Air Canada Welcomes Ratification of Two New Contracts with its Finance and Clerical Employees
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
